Several recent news items have improved my confidence in Vaxart (NASDAQ:VXRT) stock. Specifically, another columnist provided additional evidence that the company’s Covid-19 vaccine candidate could be effective even though it did not spur the production of “neutralizing antibodies” in most participants in a Phase I trial. Source: shutterstock.com/PhotobyTawat Moreover, another company agreed to license a
Small-cap stocks are public companies with market capitalizations between $300 million and $2 billion. Many small-cap companies aren’t household names. In addition, the prices of small-cap growth stocks tend to be more volatile than those of larger companies. Why should an investor pour capital into the small-cap companies when there are exciting growth stocks out
I don’t know many investors who don’t like dividends. However, there are many investors who would opt for either dividend income or earnings and revenue growth. This divide between growth and dividend investors has left a rift among dividend stocks. But does there need to be one? Not necessarily. While we can find growth stocks
Mid-cap stocks are often overlooked. However, there are terrific dividend stocks in the mid-cap group that we think are worthy of consideration for income investors. In the world of investing, many investors focus on the biggest stocks in the market – so-called large caps – for their stability and predictability. This makes large-cap stocks generally
Increased concern over inflation and valuations have brought choppiness back to equity markets. As the stock market recovers from a volatile month of trading, investors have turned their attention towards more defensive stocks. For many market participants, dividend shares seem to be the most reasonable plays. High-yield dividend stocks are prized among income investors, as
Most investors who want to gain exposure to the financial sector focus exclusively on the well-known U.S. bank stocks, such as Wells Fargo (NYSE:WFC) and Bank of America (NYSE:BAC), and that goes for income investors as well. However, some Canadian bank stocks have much lower valuations and also have higher dividend yields than their domestic counterparts.
Merck (NYSE:MRK) has been making news lately for research into a possible pill that would treat Covid-19. The coronavirus pill has led to a surge in MRK stock. Source: Atmosphere1 / Shutterstock.com The stock has had a smooth ride over the year and is trading close to the same level as last year. It stood
Bank of America (NYSE:BAC) is worth considerably more than its present price. In fact, my view is that it’s worth somewhere between 15% and 50% more from its Jul. 7 close. That means BAC stock should trade between $45.65 and $59.63 per share. The average between these two is $52.64 per share, or about 32%
Global oil consumption is recovering from the pandemic, which has driven oil prices higher, with Brent crude rising over $70 per barrel. This rally will greatly benefit oil producers, especially oil stocks from the global majors that rely more heavily on the price of oil. In addition, several top oil stocks pay high dividend yields
Exxon Mobil (NYSE:XOM) stock looks like it is significantly undervalued at today’s price. On July 8, it closed at $60.14, but XOM stock has a very attractive valuation. For example, it sports a very healthy 5.76% dividend yield and trades for just 16 times this year’s forecast earnings. Source: Jonathan Weiss / Shutterstock.com My valuation
In most cases, taking longshot bets in the market don’t pan out. However, for those brave contrarians that bought publicly traded securities during the initial onslaught of the novel coronavirus pandemic, they managed to accrue incredible profitability. Many onlookers quickly followed with their own money, making the case for buying super-safe dividend stocks less appealing
The U.S. may be on the verge of a major infrastructure spending plan, and a looming infrastructure bill could be a major boost to the nation’s infrastructure stocks. Infrastructure across the country is in need of repair. Investors should always be on the hunt for potential growth catalysts. Indeed, one potential catalyst is underway today
As seen from booming travel numbers over the July 4 holiday, it’s clear that it’s not just hype that’s fueled a reopening rally for travel stocks. After getting hammered at the onset of the Covid-19 pandemic, major stocks in the airline, casino, cruise line, and hotel industries have bounced back tremendously from their lows. Things
Other than a massive trading spike in Feb. 2020 to $24.90, Vaxart (NASDAQ:VXRT) has gone nowhere. A mid-June upgrade from Piper Sandler to an “overweight” rating temporarily lifted VXRT stock, but its price remains low. Source: Photo courtesy of Vaxart, Inc. When vaccines are making headlines every day, why are Vaxart shares underperforming? And why
Investors should avoid Clean Energy Fuels (NASDAQ:CLNE) stock for now. I say that despite the fact that the shares have positive catalysts, including backing from the Reddit crowd and an ESG-friendly business. Source: ZikG / Shutterstock.com Beyond those tenuous tailwinds, there are obvious signs that Clean Energy Fuels isn’t trending up. In fact, there are
How should investors understand ContextLogic (NASDAQ:WISH) stock currently? After all, it doesn’t look like its price is currently being affected much by short interest. That short interest has fallen quickly and sat at 5.38% on July 1. Those levels should hardly have any discernible effect on share prices at all. Source: sdx15 / Shutterstock.com Perhaps
I hate to be a wet blanket. There’s a whole lot of buzz and enthusiasm surrounding San Francisco-based technology firm Marin Software (NASDAQ:MRIN) stock. Source: Gil C / Shutterstock.com Traders may be partying like there’s no tomorrow, but every party must come to an end, sooner or later. There’s been strong upward momentum in the share
Marin Software (NASDAQ:MRIN) stock has been on a roller coaster ride for the past several weeks. On June 16, it was at $1.64 per share, but then it shot up to $24.14 by July 6. It closed last week at $17.36, sporting a $190.4 million market capitalization. MRIN stock cannot sustain this valuation. The stock
Uber Technologies (NYSE:UBER) has yet to make any form of profitability. Its latest quarterly release showed that earnings were lousy and cash flow was still negative. Moreover, its cash in the bank fell and long-term debt rose. Don’t expect UBER stock to ever get profitable at this rate. This is despite what analysts are projecting.
Since I last wrote about Churchill Capital Corp IV (NYSE:CCIV) stock, much water has passed under the bridge. Source: gg_photography / Shutterstock.com We are ten days away from the inevitable merger of the SPAC with electric vehicle manufacturer Lucid Motors. Due to the previous delays of the merger, CCIV stock lost steam during the pre-merger